← Back to patent-cliff list
氢溴酸安非他酮
Tier C — Watch / tradeBupropion hydrobromide
Valeant
Originator
2008
First approval
-
Expiry (public)
$0.11B ▲
Peak sales
化学药
Type
Targets：NET、DAT、Adrenoceptors
Brand：Aplenzin
Indications (approved)：季节性情感障碍、重度抑郁症
Regional status
US
批准上市
2008-04-23
EU
无进展
2006-05-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bupropion hydrobromide?
Approved indications include: 季节性情感障碍, 重度抑郁症.
When does the Bupropion hydrobromide patent expire?
No public expiry year is available for Bupropion hydrobromide yet; this page updates once verified.
How do I get a quote for Bupropion hydrobromide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24